Secondary glaucoma

Clinical and Experimental Optometry

Volumn 83, Issue 3, 2000, Pages 190-194

  Hall, Anthony J H ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Corticosteroid; Glaucoma; Pigment dispersion; Pseudoexfoliation; Traumatic glaucoma

Indexed keywords

EID: 15944409522     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2000.tb04914.x     Document Type: Article

References (31)

1. Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998; 105: 733–739.
2. Strohl A, Pozzi S, Wattiez R, Roesen B, Mino de Kaspar H, Klauss V. Secondary glaucoma in Paraguay. Aetiology and incidence. Ophthalmology 1999; 96: 359–363.
3. Lee WR. Doyne Lecture. The pathology of the outflow system in primary and secondary glaucoma. Eye 1995; 9: 1–23.
4. Farrar SM, Shields MB. Current concepts in pigmentary glaucoma. Surv Ophthalmol. 1993; 37: 233–252.
5. Breingan PJ, Esaki K, Ishikawa H, Liebmann JM, Greenfield DS, Ritch R. Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome. Arch Ophthalmol 1999; 117: 325–328.
6. Sone H, Okuda Y, Kawakami Y, Hanatani M, Suzuki H, Kozawa T, Honmura S, Yamashita K. Vascular endothelial growth factor level in aqueous humour of diabetic patients with rubeotic glaucoma is markedly elevated. Diabetes Care 1996; 19: 1306–1307.
7. Chandler PA, Grant WM. Lectures on glaucoma. Philadelphia: Lea and Febiger, 1965: 268.
8. Mills RP, Reynolds A, Emond MJ, Barlow WE, Leen MM. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology 1996; 103: 299–305.
9. Moorthy RS, Mermoud A, Baerveldt G, Minckler DS, Lee PP, Rao NA. Glaucoma associated with uveitis. Surv Ophthalmol 1997; 41: 361–394.
10. Panek WC, Holland GN, Lee DA, Christensen RE. Glaucoma in patients with uveitis. Br J Ophthalmol 1990; 74: 223–227.
11. Valimaki J, Airaksinen PJ, Tuulonen A. Molteno implantation for secondary glaucoma in juvenile rheumatoid arthritis. Arch Ophthalmol 1997; 115: 1253–1256.
12. Clarke WN, Noel LP. Outpatient treatment of microscopic and rim hyphemas in children with tranexamic acid. Can J Ophthalmol 1993; 28:325–327.
13. Brady KM, Atkinson CS, Kilty LA, Hiles DA. Glaucoma after cataract extraction and posterior chamber lens implantation in children. J Cat Refract Surg 1997; 23 Suppl 1: 669–674.
14. Sihota R, Sood NN, Agarwal HC. Traumatic glaucoma. Acta Ophthalmol 1995; 73: 252–254.
15. Salmon JF, Mermoud A, Ivey A, Swanevelder SA, Hoffman M. The detection of post-traumatic angle recession by gonioscopy in a population-based glaucoma survey. Ophthalmology 1994; 101: 1844–1850.
16. Mermoud A, Salmon JF, Straker C, Murray AD. Post-traumatic angle recession glaucoma: a risk factor for bleb failure after trabeculectomy. Br J Ophthalmol 1993; 77: 631–634.
17. Mermoud A, Salmon JF, Barren A, Straker C, Murray AD. Surgical management of post-traumatic angle recession glaucoma. Ophthalmology 1993; 100: 634–642.
18. Kim DD, Doyle JW, Smith ME. Intraocular pressure reduction following phacoemulsification cataract extraction with posterior chamber lens implantation in glaucoma patients. Ophthal Surg Lasers 1999; 30: 37–40.
19. Shingleton BJ, Gamell LS, O’Donoghue MW, Baylus SL, King R. Long-term changes in intraocular pressure after clear corneal phacoemulsification: normal patients versus glaucoma suspect and glaucoma patients. J Cat Refract Surg 1999; 25: 885–890.
20. Vilar NF, Flynn HW Jr, Smiddy WE, Murray TG, Davis JL, Rubsamen PE. Removal of retained lens fragments after phacoemulsification reverses secondary glaucoma and restores visual acuity. Ophthalmology 1997; 104:787–791.
21. Chien AM, Schmidt CM, Cohen EJ, Rajpal RK, Sperber LT, Rapuano CJ, Moster M, Smith M, Laibson PR. Glaucoma in the immediate postoperative period after penetrating keratoplasty. Am J Ophthalmol 1993; 115:711–714.
22. Ing JJ, Ing HH, Nelson LR, Hodge DO, Bourne WM. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology 1998; 105: 1855–1865.
23. Sihota R, Sharma N, Panda A, Aggarwal HC, Singh R. Post-penetrating keratoplasty glaucoma: risk factors, management and visual outcome. Aust NZ J Ophthalmol 1998; 26: 305–309.
24. Perry HD, Donnenfeld ED, Acheampong A, Kanellopoulos AJ, Sforza PD, D’Aversa G, Wallerstein A, Stern M. Topical Cyclosporin A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% Cyclosporin A into the cornea and anterior chamber. CLAO Journal 1998; 24: 159–165.
25. Ayyala RS, Pieroth L, Vinals AF, Goldstein MH, Schuman JS, Netland PA, Dreyer EB, Cooper ML, Mattox C, Frangie JP, Wu HK, Zurakowski D. Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium: YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. Ophthalmology 1998; 105: 1550–1556.
26. Montanari P, Troiano P, Marangoni P, Pinotti D, Ratiglia R, Miglior M. Glaucoma after vitreo-retinal surgery with silicone oil injection: epidemiologic aspects. Int Ophthalmol 1996:20:29–31.
27. Armaly ME. Effect of corticosteroids on intraocular pressure and fluid dynamics II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol 1963; 70: 492–499.
28. Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol 1963; 70: 500–507.
29. Akingbehin AO. Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%. Br J Ophthalmol 1983; 67: 661–663.
30. Urban RC, Dreyer EB. Corticosteroid induced glaucoma. Int Ophthalmol Clin 1993; 33: 135–139.
31. Lee V, Cree IA, Hungerford JL. Ring melanoma—a rare cause of refractory glaucoma. Br J Ophthalmol 1999; 83: 194–198.